Cefixime Capsule
Product Images NDC 59651-647

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Cefixime (NDC 59651-647). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Package Label-principal Display Panel (400 mg Container Label (50 Capsules Bottle))

This text provides details about Cefixime Capsules with 400 mg of cefixime USP. The prescription-only medication is distributed by Aurobindo Pharma USA, Inc. Each capsule must be stored at 20° to 25°C (68° to 77°F), with excursions permitted between 15° to 30°C (59° to 86°F). This package is not for household dispensing and must be dispensed in tight light-resistant containers. The manufacturing is done in India, and the package includes a code for tracking purposes.*

FDA Label Image

Package Label-principal Display Panel (400 mg Container Carton Label (50 Capsules Bottle))

The text provides details about Cefixime Capsules containing 400 mg of USP cfime and states the recommended storage conditions. The dosage information is referred to accompany the prescribing information. Additionally, the text mentions the distributor as Aurobindo Pharma USA with a listed address. It also includes a control number and indicates the product is for prescription-only use. It is recommended to consult the accompanying prescribing information for proper usage guidelines.*

FDA Label Image

Str (Cefixime Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.